Loading…
Sectoral / Thematic · Nippon India Mutual Fund · AMFI code 102431Nippon India Pharma Fund
Disclosed for 84 months, Sep 2019 to Aug 2026.Published as: NIPPON INDIA PHARMA FUND (An Open Ended Equity Scheme Investing In Pharma Sector)
Portfolio value
₹9,479 Cr
up ₹200 Cr vs Jul 2026
- Stocks held
- 36
- up 1 vs Jul 2026
- Top 10 weight
- 56.8%
- of the portfolio in its ten largest
- Cash & debt
- 2.0%
- cash, money market and debt
- Moves this month
- 1 in · 0 out
- added to 10, trimmed 14
Nippon India Pharma Fund is an active equity fund in the Sectoral / Thematic category from Nippon India Mutual Fund. In August 2026 it disclosed 36 stocks worth ₹9,479 Cr, up ₹200 Cr from Jul 2026. Its largest positions were Sun Pharmaceutical Industries Limited (12.4%), Divi's Laboratories Limited (7.0%), Lupin Limited (6.4%); the ten largest together made up 56.8% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 75.0% of its equity. Cash and debt stood at 2.0%. Compared with Jul 2026 the fund entered 1 new stock and exited 0.
Against 226 other Sectoral / Thematic funds
Concentration
76%
Top-10 weight is higher than 76% of peers
Breadth
31%
Holds more stocks than 31% of peers
Cash
33%
Holds more cash than 33% of peers
Holdings in August 2026
Download CSVEvery line the fund disclosed, with the change against Jul 2026. Click a column to sort; click a company to see every fund that owns it.
- Weight
- 12.37%
- Δ weight
- down 0.95 pts
- Value
- ₹1,172 Cr
- Δ value
- down ₹63.1 Cr
- Status
- Trimmed
- Weight
- 7.00%
- Δ weight
- up 0.48 pts
- Value
- ₹663 Cr
- Δ value
- up ₹58.6 Cr
- Status
- Added
- Weight
- 6.43%
- Δ weight
- down 0.82 pts
- Value
- ₹609 Cr
- Δ value
- down ₹63.1 Cr
- Status
- Trimmed
- Weight
- 6.09%
- Δ weight
- up 0.06 pts
- Value
- ₹577 Cr
- Δ value
- up ₹18 Cr
- Status
- Added
- Weight
- 5.15%
- Δ weight
- down 0.15 pts
- Value
- ₹488 Cr
- Δ value
- down ₹3.2 Cr
- Status
- Trimmed
- Weight
- 4.93%
- Δ weight
- down 0.08 pts
- Value
- ₹468 Cr
- Δ value
- up ₹2.6 Cr
- Status
- Added
- Weight
- 4.09%
- Δ weight
- up 0.35 pts
- Value
- ₹388 Cr
- Δ value
- up ₹41.1 Cr
- Status
- Added
- Weight
- 3.94%
- Δ weight
- up 0.31 pts
- Value
- ₹373 Cr
- Δ value
- up ₹37 Cr
- Status
- Added
- Weight
- 3.47%
- Δ weight
- up 0.06 pts
- Value
- ₹329 Cr
- Δ value
- up ₹12.5 Cr
- Status
- Added
- Weight
- 3.31%
- Δ weight
- up 0.65 pts
- Value
- ₹314 Cr
- Δ value
- up ₹67.4 Cr
- Status
- Added
- Weight
- 2.92%
- Δ weight
- down 0.22 pts
- Value
- ₹277 Cr
- Δ value
- down ₹15 Cr
- Status
- Trimmed
- Weight
- 2.84%
- Δ weight
- up 0.27 pts
- Value
- ₹270 Cr
- Δ value
- up ₹31 Cr
- Status
- Added
- Weight
- 2.68%
- Δ weight
- up 0.26 pts
- Value
- ₹254 Cr
- Δ value
- up ₹29.1 Cr
- Status
- Added
- Weight
- 2.51%
- Δ weight
- down 0.18 pts
- Value
- ₹238 Cr
- Δ value
- down ₹11.6 Cr
- Status
- Trimmed
- Weight
- 2.45%
- Δ weight
- down 0.06 pts
- Value
- ₹232 Cr
- Δ value
- down ₹56 L
- Status
- Held
- Weight
- 2.44%
- Δ weight
- up 0.28 pts
- Value
- ₹231 Cr
- Δ value
- up ₹30.7 Cr
- Status
- Added
- Weight
- 2.25%
- Δ weight
- up 0.15 pts
- Value
- ₹213 Cr
- Δ value
- up ₹18.7 Cr
- Status
- Added
- Weight
- 2.13%
- Δ weight
- down 0.11 pts
- Value
- ₹202 Cr
- Δ value
- down ₹6 Cr
- Status
- Trimmed
- Weight
- 2.04%
- Δ weight
- down 0.01 pts
- Value
- ₹194 Cr
- Δ value
- up ₹2.9 Cr
- Status
- Added
- Cash, TREPS & receivables
- Weight
- 2.00%
- Δ weight
- down 0.68 pts
- Value
- ₹190 Cr
- Δ value
- down ₹58.9 Cr
- Status
- Trimmed
- Weight
- 1.82%
- Δ weight
- down 0.19 pts
- Value
- ₹173 Cr
- Δ value
- down ₹13.7 Cr
- Status
- Trimmed
- Weight
- 1.66%
- Δ weight
- down 0.14 pts
- Value
- ₹157 Cr
- Δ value
- down ₹10.1 Cr
- Status
- Trimmed
- Weight
- 1.63%
- Δ weight
- up 0.10 pts
- Value
- ₹155 Cr
- Δ value
- up ₹12.3 Cr
- Status
- Added
- Weight
- 1.57%
- Δ weight
- down 0.08 pts
- Value
- ₹149 Cr
- Δ value
- down ₹4.4 Cr
- Status
- Trimmed
- Weight
- 1.48%
- Δ weight
- up 0.02 pts
- Value
- ₹140 Cr
- Δ value
- up ₹5.2 Cr
- Status
- Added
- Weight
- 1.39%
- Δ weight
- up 0.33 pts
- Value
- ₹132 Cr
- Δ value
- up ₹33.7 Cr
- Status
- Added
- Weight
- 1.29%
- Δ weight
- down 0.08 pts
- Value
- ₹122 Cr
- Δ value
- down ₹5.1 Cr
- Status
- Trimmed
- Weight
- 1.25%
- Δ weight
- down 0.32 pts
- Value
- ₹119 Cr
- Δ value
- down ₹27.4 Cr
- Status
- Trimmed
- Weight
- 1.20%
- Δ weight
- up 0.28 pts
- Value
- ₹114 Cr
- Δ value
- up ₹28.2 Cr
- Status
- Added
- Weight
- 1.11%
- Δ weight
- up 0.11 pts
- Value
- ₹105 Cr
- Δ value
- up ₹12.5 Cr
- Status
- Added
- Weight
- 1.09%
- Δ weight
- up 0.17 pts
- Value
- ₹103 Cr
- Δ value
- up ₹17.9 Cr
- Status
- Added
- Weight
- 0.99%
- Δ weight
- down 0.08 pts
- Value
- ₹93.8 Cr
- Δ value
- down ₹5.8 Cr
- Status
- Trimmed
- Weight
- 0.93%
- Δ weight
- down 0.13 pts
- Value
- ₹88.5 Cr
- Δ value
- down ₹10.1 Cr
- Status
- Trimmed
- Weight
- 0.47%
- Δ weight
- up 0.04 pts
- Value
- ₹44.7 Cr
- Δ value
- up ₹4.4 Cr
- Status
- Added
- Weight
- 0.46%
- Δ weight
- down 0.09 pts
- Value
- ₹43.5 Cr
- Δ value
- down ₹7.2 Cr
- Status
- Trimmed
- Weight
- 0.44%
- Δ weight
- up 0.44 pts
- Value
- ₹41.3 Cr
- Δ value
- up ₹41.3 Cr
- Status
- New
- Weight
- 0.17%
- Δ weight
- down 0.00 pts
- Value
- ₹16.2 Cr
- Δ value
- up ₹28 L
- Status
- Added
What changed, Jul 2026 to Aug 2026
New New positions (1)
- MOLBIO DIAGNOSTICS LIMITED0.4% · ₹41.3 Cr
Exited Exited (0)
None.
Added Biggest additions
- GlaxoSmithKline Pharmaceuticals Limitedup ₹67.4 Cr (+0.65% pts)
- Divi's Laboratories Limitedup ₹58.6 Cr (+0.48% pts)
- Mankind Pharma Limitedup ₹41.1 Cr (+0.35% pts)
- Sai Life Sciences Limitedup ₹37 Cr (+0.31% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Jul 2026, the weight rose most in Healthcare Equipment & Supplies (+0.4 pts), and fell most in Healthcare Services (−0.2 pts) and Retailing (−0.2 pts).
- Healthcare Equipment & Supplies0.0% → 0.4%new+0.4 pts
- Healthcare Services21.7% → 21.5%−0.2 pts
- Retailing2.8% → 2.6%−0.2 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Aug 2023 | Aug 2025 | Feb 2026 | May 2026 | Jul 2026 | Aug 2026 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 77.8% | 75.5% | 74.2% | 73.4% | 75.1% | 75.0% |
| Healthcare Services | 16.3% | 20.2% | 21.7% | 22.4% | 21.7% | 21.5% |
| Retailing | 4.7% | 3.7% | 3.7% | 3.8% | 2.8% | 2.6% |
| Pharmaceuticals | 1.1% | 0.6% | 0.4% | 0.5% | 0.4% | 0.5% |
| Healthcare Equipment & Supplies | 0.2% | — | — | — | — | 0.4% |
Allocation in Aug 2026change vs Jul 2026
- Pharmaceuticals & Biotechnology (24)75.0%▼ 0.1 pts
- Healthcare Services (9)21.5%▼ 0.2 pts
- Retailing (1)2.6%▼ 0.2 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal.
Cash & debt, Aug 2026
2.0%
▼ 0.7 pts vs Jul 2026
- Cash alone
- 2.0%
- cash and net receivables
- A year earlier
- 0.5%
- Aug 2025 · now ▲ 1.5 pts
- Last 12 months
- 0.3% – 2.7%
- lowest to highest · record 5.9% in May 2021
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.